Arcellx, Inc.
$115.07
$0.00(0.00%)
Arcellx, Inc.
ACLX
$115.07
$0.00(0.00%)
Arcellx, Inc.
ACLX
NASDAQ
$115.07
$0.00(0.00%)
Chart
Upcoming Earnings
Next report date
May 7, 2026
Report period
Q2 2026
EPS Estimate
$-1.13
Revenue Estimate
$6.07M
Key stats
52-Week Range$115.07
$47.86
$115.13
Market capitalization
$6.73BDividend yield (indicated)
0.00%Price to earnings Ratio (TTM)
-28.30Basic EPS (TTM)
$-4.07Net income (TTM)
$-228.93MRevenue (TTM)
$22.29MAvg. volume
2.42MBeta (1Y)
0.25Employees
163Market capitalization
$6.73BDividend yield (indicated)
0.00%Price to earnings Ratio (TTM)
-28.30Basic EPS (TTM)
$-4.07Net income (TTM)
$-228.93MRevenue (TTM)
$22.29MAvg. volume
2.42MBeta (1Y)
0.25Employees
163Screener Quick Check
Sign in to check this stock against your screeners
Sign InAbout Arcellx, Inc.
Sector
Healthcare
Industry
Biotechnology
CEO
Rami Elghandour
Website
arcellx.comHeadquarters
25 West Watkins Mill Road, Redwood City, MD, 20878
IPO Date
2022-02-04
Identifiers
ISIN
US03940C1009Description
Arcellx, Inc., a clinical-stage biotechnology company, engages in the development of various immunotherapies for patients with...
Related Stocks
$74.93
1D:
-1.9%
1Y:
436.0%
US04280A1007Healthcare
Mkt Cap
$10.49B
P/E Ratio TTM
51.8
Revenue TTM
$1.09B
Beta
1.27
Earnings TTM
$202.27M
Dividend Yield TTM
0.00%
$55.64
1D:
-4.9%
1Y:
62.3%
US92243G1085Healthcare
Mkt Cap
$8.03B
P/E Ratio TTM
-10.1
Revenue TTM
$0.00
Beta
1.39
Earnings TTM
$-766.63M
Dividend Yield TTM
0.00%
Dividend Overview
This company does not pay dividends
Financials
Performance
Margin trends
Debt level and coverage
Earnings
Next: Q2 '26
Actual
Estimate
Performance
Margin trends
Debt level and coverage
Earnings
Next: Q2 '26
Actual
Estimate